Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2022 Filed Feb 3, 2022 22:09 UTC |
White Anne E.SVP & Pres-Lilly Neuroscience
|
Exercise / conversionCommon Stock | 9,368 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000032 · wf-form4_164392615619605.xml · nonDerivative · entry 1 White Anne E. · CIK 0001752313 · SVP & Pres-Lilly Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:21 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 46 | $247.07 | $11,365.22 |
DisclosureSEC source: 0000059478-22-000005 · wf-form4_164271724684357.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,142 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:23 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 39 | $247.07 | $9,635.73 |
DisclosureSEC source: 0000059478-22-000007 · wf-form4_164271737120147.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:25 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 51 | $247.07 | $12,600.57 |
DisclosureSEC source: 0000059478-22-000009 · wf-form4_164271748550939.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,538 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:27 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 40 | $247.07 | $9,882.80 |
DisclosureSEC source: 0000059478-22-000011 · wf-form4_164271765095001.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:30 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 40 | $247.07 | $9,882.80 |
DisclosureSEC source: 0000059478-22-000013 · wf-form4_164271781581623.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,842 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 15:01 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,614 | $279.55 | $1,010,275.63 |
DisclosureSEC source: 0001209191-22-000027 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,463,810 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.50 to $279.895, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:09 UTC |
Van Naarden JacobSVP, CEO LoxoONC, Pres LlyONC
|
GrantRestricted Stock Unit · Derivative | 3,618 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000248 · wf-form4_164089857090230.xml · derivative · entry 1 Van Naarden Jacob · CIK 0001661254 · SVP, CEO LoxoONC, Pres LlyONC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,618 Underlying: Common Stock · 3,618 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest on February 1, 2024. F2 · derivative.expiration_date: The restricted stock units vest on February 1, 2024. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 16:25 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,570 | $279.53 | $997,924.96 |
DisclosureSEC source: 0001209191-21-071351 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,467,424 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.50 to $279.88, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:29 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 37 | $263.48 | $9,748.76 |
DisclosureSEC source: 0000059478-21-000244 · wf-form4_164020853697362.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:26 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000242 · wf-form4_164020836805321.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,096 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:34 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 8 | $263.48 | $2,107.84 |
DisclosureSEC source: 0000059478-21-000246 · wf-form4_164020884062460.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,095 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,920 | $283.06 | $1,392,635.52 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,470,994 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.715 to $283.51, inclusive. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,579 | $281.79 | $2,981,035.25 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,475,914 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.50 to $282.49, inclusive. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 29,571 | $280.90 | $8,306,346.05 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,486,493 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.50 to $281.495, inclusive. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 132,546 | $279.82 | $37,088,756.63 |
DisclosureSEC source: 0001209191-21-070263 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,516,064 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.50 to $280.495, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 11,377 | $275.23 | $3,131,257.58 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,648,610 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.13 to $275.38, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 24,067 | $274.62 | $6,609,159.21 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,659,987 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.06 to $274.99, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 26,223 | $273.44 | $7,170,338.45 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,684,054 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.03 to $274.02, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 36,370 | $272.66 | $9,916,607.83 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,710,277 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.03 to $273.0292, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 51,126 | $271.52 | $13,881,936.02 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,746,647 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.03 to $272.02, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,731 | $270.49 | $5,337,038.19 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,797,773 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.0217 to $271.01, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 13,222 | $269.65 | $3,565,338.74 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,817,504 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.02 to $270.01, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,808 | $268.41 | $2,364,120.05 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,830,726 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.00 to $268.98, inclusive. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:59 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,076 | $267.37 | $3,763,542.35 |
DisclosureSEC source: 0001209191-21-069987 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,839,534 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:42 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000218 · wf-form4_163718534875121.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:44 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000220 · wf-form4_163718546940197.xml · nonDerivative · entry 2 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,035 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:44 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 8 | $258.43 | $2,067.44 |
DisclosureSEC source: 0000059478-21-000220 · wf-form4_163718546940197.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,358 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:46 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000222 · wf-form4_163718559717387.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,181 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:51 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000224 · wf-form4_163718589785740.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,564 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:14 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000233 · wf-form4_163718722060858.xml · nonDerivative · entry 2 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,878 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:14 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 42 | $258.43 | $10,854.06 |
DisclosureSEC source: 0000059478-21-000233 · wf-form4_163718722060858.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,201 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:16 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000234 · wf-form4_163718735403894.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,440 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:17 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000235 · wf-form4_163718742946790.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,307 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:19 UTC |
Walker KarenDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000236 · wf-form4_163718755214286.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,950 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:20 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000237 · wf-form4_163718763368528.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,704 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:22 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000238 · wf-form4_163718772026884.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,766 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:23 UTC |
ESKEW MICHAEL LDirector
|
GrantCommon Stock | 677 | $258.43 | $174,957.11 |
DisclosureSEC source: 0000059478-21-000239 · wf-form4_163718780965014.xml · nonDerivative · entry 1 ESKEW MICHAEL L · CIK 0001227734 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,080 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:25 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 621 | $258.43 | $160,485.03 |
DisclosureSEC source: 0000059478-21-000240 · wf-form4_163718789062421.xml · nonDerivative · entry 2 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,014 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 22:25 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 37 | $258.43 | $9,561.91 |
DisclosureSEC source: 0000059478-21-000240 · wf-form4_163718789062421.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 56 | $271.00 | $15,176.00 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,853,610 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 44,240 | $270.48 | $11,966,123.68 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,853,666 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.98, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 74,067 | $269.59 | $19,967,796.60 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,897,906 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.00 to $269.99, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,469 | $268.34 | $4,419,357.34 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,971,973 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.00 to $268.99, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 25,227 | $267.43 | $6,746,355.70 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,988,442 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.00 to $267.9887, inclusive. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:19 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 34,941 | $266.29 | $9,304,508.77 |
DisclosureSEC source: 0001209191-21-063054 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,013,669 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.00 to $266.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,028 | $256.37 | $776,273.22 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,048,610 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.01 to $256.75, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,541 | $255.38 | $2,181,166.42 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,051,638 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.00 to $255.97, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 22,959 | $254.36 | $5,839,828.28 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,060,179 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.00 to $254.99, inclusive. Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,267 | $253.66 | $10,467,869.75 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,083,138 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.00 to $253.9975, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.